Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery

PHASE4TerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

July 12, 2023

Study Completion Date

July 12, 2023

Conditions
GlaucomaCataract
Interventions
DRUG

Dexamethasone Ophthalmic Insert

DEXTENZA® is a 3mm long gel-like cylinder that is inserted in the punctum, a natural opening in the lower eyelid. DEXTENZA® is activated by the eye's moisture. DEXTENZA® delivers 0.4 mg dexamethasone, a liquid corticosteroid, onto the surface of the eye automatically for up to 30 days after eye surgery. Dexamethasone is used to reduce inflammation and eye pain. This arm will also receive the standard of care topical ofloxacin eye drop antibiotic regimen.

DRUG

Prednisolone Acetate 1% Oph Susp

Prednisolone acetate 1% eye drops are used 2-4 times daily for 30 days as the current standard of care for treating inflammation and eye pain after cataract surgery. Prednisolone, like dexamethasone, is a steroid. This arm will also receive the standard of care topical ofloxacin eye drop antibiotic regimen.

Trial Locations (1)

10469

The New York Eye Surgery Center, The Bronx

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ocular Therapeutix, Inc.

INDUSTRY

lead

The New York Eye Surgery Center

OTHER